Page last updated: 2024-09-04

pralnacasan and tetomilast

pralnacasan has been researched along with tetomilast in 1 studies

Compound Research Comparison

Studies
(pralnacasan)
Trials
(pralnacasan)
Recent Studies (post-2010)
(pralnacasan)
Studies
(tetomilast)
Trials
(tetomilast)
Recent Studies (post-2010) (tetomilast)
19072016

Protein Interaction Comparison

ProteinTaxonomypralnacasan (IC50)tetomilast (IC50)
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.074
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.074
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.074
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.072

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gotham, S1

Other Studies

1 other study(ies) available for pralnacasan and tetomilast

ArticleYear
Digestive Disease Week 2004. Bowel inflammation.
    IDrugs : the investigational drugs journal, 2004, Volume: 7, Issue:6

    Topics: Azepines; Cholinergic Agents; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Isoquinolines; Pyridazines; Tacrolimus; Thiazoles

2004
chemdatabank.com